International Journal of Mycobacteriology
Scope & Guideline
Connecting minds to combat infectious diseases effectively.
Introduction
Aims and Scopes
- Clinical Research on Tuberculosis and Leprosy:
The journal publishes extensive clinical research including epidemiological studies, treatment outcomes, and case reports that enhance the understanding of TB and leprosy in various populations. - Diagnostics and Biomarkers:
A significant focus is placed on the development and evaluation of diagnostic modalities, including molecular techniques and serological tests to improve early detection and management of mycobacterial infections. - Drug Resistance and Treatment Strategies:
The journal addresses the critical issue of drug resistance in mycobacteria, exploring new treatment regimens, pharmacogenomics, and the efficacy of existing and novel antimicrobial agents. - Immunology and Pathogenesis:
Research articles often delve into the immunological aspects of mycobacterial infections, including host-pathogen interactions, immune responses, and the role of genetic factors in susceptibility. - Public Health and Policy:
The journal contributes to public health discourse by publishing studies on the socio-economic impacts of TB and leprosy, vaccination strategies, and health policy implications.
Trending and Emerging
- Impact of COVID-19 on Mycobacterial Diseases:
There is a growing body of research examining the interplay between COVID-19 and mycobacterial diseases, particularly how the pandemic has affected TB diagnosis, treatment, and epidemiology. - Integrated Approaches to Drug-Resistant Tuberculosis:
Research focusing on multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) is on the rise, highlighting the urgent need for innovative treatment strategies and public health interventions. - Role of Genetic and Immunological Factors:
Emerging studies are increasingly investigating the genetic polymorphisms and immunological responses that influence susceptibility to TB and leprosy, reflecting a trend towards personalized medicine. - Use of Artificial Intelligence in Diagnostics:
The application of AI and machine learning techniques in the diagnosis and management of mycobacterial infections is becoming a prominent theme, indicating a technological advancement in the field. - Nontuberculous Mycobacterial Infections:
Research on nontuberculous mycobacteria (NTM), including their clinical implications and treatment challenges, is gaining traction as these pathogens are recognized for their significance in immunocompromised patients.
Declining or Waning
- Traditional Culture Techniques for Mycobacterial Identification:
The reliance on conventional culture methods for identifying mycobacterial species has decreased as molecular techniques such as PCR and next-generation sequencing gain prominence due to their speed and accuracy. - Basic Research on Non-Pathogenic Mycobacteria:
Research focusing on non-pathogenic mycobacteria, while still relevant, has seen a reduction in publications as the field increasingly prioritizes pathogenic strains that have significant public health implications. - Leprosy Research in Non-Endemic Regions:
Studies specifically addressing leprosy in non-endemic areas are becoming less frequent, possibly due to a global focus on tuberculosis and the need for immediate solutions to more pressing health crises.
Similar Journals
ACTA VIROLOGICA
Empowering the scientific community with groundbreaking virology studies.ACTA VIROLOGICA, a key journal in the field of virology and infectious diseases, is published by FRONTIERS MEDIA SA in Slovakia, serving the global scientific community with groundbreaking research since its inception in 1957. This esteemed journal, identified by ISSN 0001-723X and E-ISSN 1336-2305, provides a platform for rigorous peer-reviewed articles that contribute significantly to our understanding of viral pathogens and their implications in medicine. Positioned within the Q3 category for both Infectious Diseases and Miscellaneous Medicine, and a Q4 category for Virology in 2023, ACTA VIROLOGICA offers crucial insights into the evolving landscape of virology research. With its robust accessibility options, this journal appeals to a diverse readership, including researchers, healthcare professionals, and students, fostering a collaborative environment to advance the field of virology. The editorial objective is to enhance the catalog of knowledge pertaining to viruses, promoting innovative approaches in prevention, diagnostics, and treatment. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND, ACTA VIROLOGICA continues to be a vital resource in the collective efforts to combat viral disease challenges.
Infectious Diseases
Pioneering Insights in Microbiology and ImmunologyInfectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.
Emerging Microbes & Infections
Leading the charge in infectious disease innovation.Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.
JOURNAL OF INFECTIOUS DISEASES
Illuminating the Pathways of Infectious Disease KnowledgeThe JOURNAL OF INFECTIOUS DISEASES, published by OXFORD UNIV PRESS INC, is a leading peer-reviewed journal dedicated to advancing the understanding of infectious diseases through high-quality research. With an impressive impact factor reflecting its prominence in the field—ranking in the Q1 category for both Immunology and Allergy and Infectious Diseases—this journal serves as a pivotal platform for researchers, healthcare professionals, and students alike. Its extensive history, spanning over a century since its inception in 1904, highlights its established authority and commitment to the field. Based in the United Kingdom, the journal covers essential topics from clinical management to epidemiological trends, providing vital insights that inform practice and policy. Although the journal is not open access, it remains accessible to a wide audience, ensuring that critical research continues to drive innovation and best practices in infectious disease management.
Medical Mycology Journal
Bridging Research and Practice in Medical MycologyMedical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.
Journal of Clinical Virology Plus
Transforming clinical virology through open-access research.The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.
MEDICAL MYCOLOGY
Transforming Understanding of Mycological DiseasesMEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.
GERMS
Championing research that transforms health outcomes worldwide.GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.
KOREAN JOURNAL OF PARASITOLOGY
Innovating Solutions for Parasitic DiseasesKorean Journal of Parasitology is a respected publication in the field of parasitology, originating from the esteemed Korean Society of Parasitology and affiliated with Seoul National University College of Medicine. Established in 1977, this journal focuses on disseminating significant research findings related to parasitic diseases, their vectors, and control measures, serving as a vital resource for researchers, medical professionals, and students alike. Although coverage in Scopus has been discontinued as of 2022, the journal remains a valuable platform for in-depth studies within the areas of Infectious Diseases and Immunology. With an ISSN of 0023-4001 and an E-ISSN of 1738-0006, the journal promotes open access to enhance academic sharing. Despite its current Scopus rankings, which place it in the 38th percentile for Infectious Diseases and 37th percentile for Immunology and Microbiology (Parasitology), it continues to contribute to the global discourse on parasitological research, encouraging collaboration and emphasizing the importance of this field in public health.
INFECTION
Connecting Researchers to the Frontlines of InfectionINFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.